MedCity News

Emulate CEO shares the organ-chip maker’s vision to understand and predict drug response

Emulate is the leading provider of next generation in vitro biological models. Researchers use their organ-on-a-chip technology to understand and predict drug response with greater precision and ...
MD&M East

Emulate's Organ-on-Chip Technology in the 2nd Inning, Still Has Room to Grow

Emulate has raised $82 million in a series E round to help further develop and commercialize its organ-on-a-chip technology. The Boston, MA company has raised a total of $225 million since it was ...
Yahoo Finance

Emulate Launches AVA™ Emulation System to Accelerate Drug Development With First-of-its-Kind High-Throughput Organ-Chip Platform

Emulate, Inc., the world leader in Organ-on-a-Chip technology, today announced the commercial launch of the AVA™ Emulation System , a self-contained instrument that cultures, incubates, and images up ...
Business Wire

Emulate Closes $82 Million Series E Financing to Scale Amid Rapid Growth in Organ-on-a-Chip Market

BOSTON--(BUSINESS WIRE)--Emulate, Inc., a leading provider of next generation in vitro models, today announced the close of an $82 million Series E financing round led by existing investor Northpond ...
SpaceNews

Emulate Brain-Chip to Study the Effects of Microgravity on Human Brain Physiology at the International Space Station

Emulate, Inc., a leading provider of next-generation in vitro models, today announced that the Brain-Chip is being sent to the International Space Station U.S. National Laboratory (ISS National Lab) ...
Business Wire

Emulate Applauds FDA’s Roadmap to Reduce Animal Testing and Embrace Organ-Chip Technologies

BOSTON--(BUSINESS WIRE)--Emulate, Inc., a leading provider of next-generation in vitro models, today welcomed the U.S. Food and Drug Administration’s (FDA) newly announced plan to reduce reliance on ...
Seeking Alpha

Medical device developer Emulate Therapeutics sets terms for proposed $13M IPO

Medical device maker Emulate Therapeutics (EMTX) has set terms for a proposed IPO that would raise around $13M. Emulate said in a filing that it is looking to offer 2.5M shares priced between $4 and ...
STAT

‘Organ-on-a-chip’ maker Emulate names new CEO, announces new funding

A Boston startup known for its plastic chips that simulate human organs announced the appointment of a new CEO on Thursday as it ramps up its commercial portfolio with new funding. Jim Corbett will ...
The Scientist

Emulate, Inc. Unveils the Chip-R1™ Rigid Chip with a Minimally Drug-Absorbing Profile to Improve Biological Modeling for ADME and Toxicology Applications

Emulate, Inc., the leading provider of next-generation in vitro Organ-Chip models, today announced the release of its new Chip-R1™ Rigid Chip, designed to minimize drug absorption and enhance ...
PMLiVE

AstraZeneca and Emulate advance ‘organs-on-chips’ research partnership

After becoming its first big pharma partner several years ago, AstraZeneca has given Emulate a major seal of approval by embedding its ‘organs on a chip’ technology into its own research team. Each of ...
Science Daily

Synthetic cells emulate natural cellular communication

A research team has succeeded in synthesizing simple, environmentally sensitive cells complete with artificial organelles. For the first time, the researchers have also been able to emulate natural ...